These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24497296)

  • 21. Assessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis.
    Doizi S; Rodgers K; Poindexter J; Sakhaee K; Maalouf NM
    J Urol; 2016 Jun; 195(6):1799-804. PubMed ID: 26723865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology of uric acid nephrolithiasis.
    Moe OW; Abate N; Sakhaee K
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):895-914. PubMed ID: 12474637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multiregional Italian cohort of 24-hour urine metabolic evaluation in renal stone formers.
    Esperto F; Marangella M; Trinchieri A; Petrarulo M; Miano R
    Minerva Urol Nefrol; 2018 Feb; 70(1):87-94. PubMed ID: 28882031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus.
    Spatola L; Ferraro PM; Gambaro G; Badalamenti S; Dauriz M
    Metabolism; 2018 Jun; 83():225-233. PubMed ID: 29510180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 diabetes increases the risk for uric acid stones.
    Daudon M; Traxer O; Conort P; Lacour B; Jungers P
    J Am Soc Nephrol; 2006 Jul; 17(7):2026-33. PubMed ID: 16775030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
    Cameron MA; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
    J Am Soc Nephrol; 2006 May; 17(5):1422-8. PubMed ID: 16597681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes.
    Bell DS
    Diabetes Obes Metab; 2012 Apr; 14(4):299-303. PubMed ID: 21992452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kidney stones: Composition, frequency and relation to metabolic diagnosis.
    Spivacow FR; Del Valle EE; Lores E; Rey PG
    Medicina (B Aires); 2016; 76(6):343-348. PubMed ID: 27959841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Uric acid nephrolithiasis].
    Ferraro PM; Gambaro G
    G Ital Nefrol; 2015; 32 Suppl 62():. PubMed ID: 26005875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis.
    Strohmaier WL; Wrobel BM; Schubert G
    Urol Res; 2012 Apr; 40(2):171-5. PubMed ID: 21866382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder.
    Wiederkehr MR; Moe OW
    Clin Rev Bone Miner Metab; 2011 Dec; 9(3-4):207-217. PubMed ID: 25045326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of being overweight on urinary metabolic risk factors for kidney stone formation.
    Shavit L; Ferraro PM; Johri N; Robertson W; Walsh SB; Moochhala S; Unwin R
    Nephrol Dial Transplant; 2015 Apr; 30(4):607-13. PubMed ID: 25362001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and dietary factors of uric acid stone formation.
    Trinchieri A; Montanari E
    Urolithiasis; 2018 Apr; 46(2):167-172. PubMed ID: 28246885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers.
    Cameron M; Maalouf NM; Poindexter J; Adams-Huet B; Sakhaee K; Moe OW
    Kidney Int; 2012 Jun; 81(11):1123-30. PubMed ID: 22297671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiology of nephrolithiasis in France].
    Daudon M
    Ann Urol (Paris); 2005 Dec; 39(6):209-31. PubMed ID: 16425740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical profile of stone-forming patients with diabetes mellitus.
    Pak CY; Sakhaee K; Moe O; Preminger GM; Poindexter JR; Peterson RD; Pietrow P; Ekeruo W
    Urology; 2003 Mar; 61(3):523-7. PubMed ID: 12639639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences.
    Spatola L; Angelini C; Badalamenti S; Maringhini S; Gambaro G
    Urolithiasis; 2017 Oct; 45(5):457-460. PubMed ID: 27921141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes and nephrolithiasis.
    Daudon M; Jungers P
    Curr Diab Rep; 2007 Dec; 7(6):443-8. PubMed ID: 18255008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.